|
|
|
|
![]() |
| 3B3-023916 |
|
(+/-)5-Hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid,methyl ester |
| 3B3-023917 |
|
(+/-)-(6E,8Z,11Z,14Z)-5-Hydroxyeicosatetraenoic acid |
| 3B3-023918 |
|
15(S)-Hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoic acid |
| 3B3-023919 |
|
(+/-)-12-Hydroxy-5Z,8Z,10E,14Z,17Z-eicosapentaenoic acid |
| 3B3-023920 |
|
11S-Hydroxy-5Z,8Z,12E,14Z,17Z-eicosapentaenoic acid |
| 3B3-023921 |
|
9S-Hydroxy-5Z,7E,11Z,14Z,17Z-eicosapentaenoic acid |
| 3B3-023922 |
|
5S-Hydroxy-6E,8Z,11Z,14Z,17Z-eicosapentaenoic acid |
| 3B3-023923 |
|
15-Deoxy-D-12,14-prostaglandin J2 |
| 3B3-023924 |
|
11-Oxo-15S-hydroxy-prosta-5Z,9,12E-trien-1-oic acid |
| 3B3-023925 |
|
11-Oxo-15S-Hydroxy-prosta-5Z,9,13E-trien-1-oic acid |
| 3B3-023926 |
|
9alpha,11alpha,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic acid,1,15-lactone |
| 3B3-023927 |
|
9-Oxo-11alpha,15S-dihydroxy-prosta-5Z,13E,17Z,trien-1-oic acid |
| 3B3-023928 |
|
9,15-Dioxo-11alpha-hydroxy-prosta-5Z,13E-dien-1-oic acid |
| 3B3-023929 |
|
11-Deoxy-13,14-dihydro-15-keto-11beta,16chi-cycloprostaglandin E2 |
| 3B3-023930 |
|
9-Oxo-11alpha,15S-dihydroxy-(8beta)-prosta-5Z,13E-dien-1-oic acid |
| 3B3-023931 |
|
9-Oxo-15S-hydroxy-prost-13E-en-1-oic acid |
| 3B3-023932 |
|
9-Oxo-11aloha,15S-dihydroxy-(8beta)-prost-13E-en-1-oic acid |
| 3B3-023933 |
|
13,14-Dihydro-15-keto prostaglandin D2 |
| 3B3-023934 |
|
9-Oxo-15S-hydroxy-prosta-5Z,8(12),13E-trien-1-oic acid |
| 3B3-023935 |
|
Prostaglandin A3 |
| |
|
|
| |
|
|
| |
|
Home Previous 1306 1307 1308 1309 1310 Next End |
|
|
| |
|
| Home - About Us - Contact Us - Bookmark |
|
 |
| Copyright @ 2021 3bsc.com Inc. All Rights Reserved |
| ¶õICP±¸2021000677ºÅ |
¶õ¹«Íø°²±¸ 42011102004317ºÅ |
|
|